Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
Remark
Therapeutic category:
3999
ATC code:
M05BA01
Chemical structure group:
DG00780
Product (DG00780):
D00314<JP>
Efficacy
Antiresorptive, Osteoporosis agent
Disease
Paget's disease of bone [DS:H00437]
Comment
Bisphosphonate
Interaction
Structure map
map07047
Osteoporosis drugs
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BA Bisphosphonates
M05BA01 Etidronic acid
D00314 Etidronate disodium (JP18/USP) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D00314 Etidronate disodium (JP18/USP)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
DG00780 Etidronic acid
D00314 Etidronate disodium
Drug classes [BR:br08332]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
D00314 Etidronate disodium
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00314 Etidronate disodium
D00314 Etidronate disodium tablets
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
DG00780 Etidronic acid
Other DBs
CAS:
7414-83-7
PubChem:
7847380
ChEBI:
4906
LigandBox:
D00314
NIKKAJI:
J31.845K
KCF data
ATOM 13
1 C1d C 31.3375 -15.6357
2 P1b P 30.0326 -15.6297
3 P1b P 32.6071 -15.6357
4 C1a C 31.3374 -17.0721
5 O1a O 31.3897 -14.1230
6 O1c O 30.0326 -17.1309
7 O1c O 28.5670 -15.5774 #-
8 O1c O 30.0326 -14.1289
9 O1c O 32.5953 -17.1309
10 O1c O 34.0315 -15.6010 #-
11 O1c O 32.6071 -14.1289
12 Z Na 35.3500 -15.5400 #+
13 Z Na 26.3900 -15.6100 #+
BOND 10
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 1
6 2 7 1
7 2 8 2
8 3 9 1
9 3 10 1
10 3 11 2